Replies to post #354638 on Amarin Corp Plc (AMRN)

[Skipperdog11]

"Here's a bear article poo-pooing Amarin"

I don't see any part of this article that is motivated by a negative slant to induce dumping of the stock. Seems pretty well thought out and well communicated. If this company is not in "grind it out mode", I've never seen one that is. Amarin must proceed at near perfection to survive. The company must show rapid results in Germany for anyone to believe the rest of the globe will be adequately addressed by this small operating company.

As many here do, I see this company acting as one that is built for sale. If you just "back of the napkin" the time and costs it will take to be up and running outside of Germany, it details to me a several year journey to sustained profitability and growth. Seems most feel comfortable with current cash on hand to fund the expansion. I can't see it happening without more financing unless the growth is governed down to a trickle of what is possible.

B/O changes everything in a heartbeat for us, but if you listen to leadership and believe they fully intend to build this out on their own, then it is very hard to dismiss the points made by the horse trading guy.

[bidmark]

STS is a ward of the state.

[Birdbrain Ideas]

"Seeking Alpha" articles are one step up from sending a mass email or shouting what you think from the top of a tall building. They are behind a firewall and most people can't even read the submissions, which seem often to be written by regular Joes who neither know how to write or invest.

I guess it is true that it will be a long, slow slog for Amarin investors unless the company tomorrow announces that Pfizer will join it in Europe or the U.S. or both to help sell Vascepa, or announces spectacular results in the NASH or COVID trials, or announces a partnership with any Big Pharma or announces a buyout, or announces a new product such as a combined statin-Vascepa pill or announces that sales in Europe are occurring more rapidly than expected or announces a settlement with Health Net or announces that sales will begin in England in January or announces ...

In other words, it's a long, slow slog for Amarin investors until it's not.